Skip to content

Children*s Autoimmunity related to Neuropsychiatric symptoms, Chorea and Epilepsy

Children*s Autoimmunity related to Neuropsychiatric symptoms, Chorea and Epilepsy - CHANCE

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON41693
Enrollment
600
Registered
2014-06-20
Start date
2015-01-28
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

'autoimmune encephalitis' and 'inflamed brain'

Interventions

None listed

Sponsors

Erasmus MC, Universitair Medisch Centrum Rotterdam
Lead Sponsor

Eligibility

Age
2 Years to 17 Years

Inclusion criteria

Inclusion criteria: - Age under 18 years - Clinical profile fits one of the four groups: 1. limbic or cortical encephalitis, 2. new-onset seizures/status epilepticus without known cause, 3. acute encephalopathy with fever/inflammation-mediated status epilepticus or 4. acute-onset neuropsychiatric symptoms of basal ganglia dysfunction, like chorea . - No known cause, like a bacteria, virus, haemorrhage, stroke, genetic cause.

Exclusion criteria

Exclusion criteria: - 18 years or over - Patient and/ or legal representative is withholding informed consent - Patient objects after initial informed consent (see paragraph 8.3).

Design outcomes

Primary

MeasureTime frame
1. The characterization of new antibody-related clinical syndromes; 2. The frequency of the individual antibody-mediated syndromes in children; 3. The outcome of the individual antibody-mediated syndromes in children.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)